BeiMedPlus | España

Philipp Staber, Gianluca Gaidano, Barbara Eichhorst

Satellite Symposium: New avenues to improving outcomes for CLL patients

Overview of new approaches that aim to improve outcomes for patients with chronic lymphocytic leukemia (CLL) presented at the ESH 3^rd Translational Research Conference: Chronic Lymphocytic Leukaemia.

Video

30 Ene 2024

BeiGene

Therapeutic options for R/R B-cell malignancies

Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

Lectura

31 Oct 2023

BeiGene

Therapeutic option for R/R FL

Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

Lectura

26 Oct 2023

BeiGene

Therapeutic option for patients with R/R MZL

Factsheet describing the efficacy and safety of a BTKi in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

Lectura

26 Oct 2023

BeiGene

Therapeutic options for WM

Factsheet describing the treatment of Waldenström's macroglobulinemia (WM) by inhibiting BTK.

Lectura

26 Oct 2023

Cargar más

Satellite Symposium: New avenues to improving outcomes for CLL patients

Therapeutic options for R/R B-cell malignancies

Therapeutic option for R/R FL

Therapeutic option for patients with R/R MZL

Therapeutic options for WM

Está a punto de abandonar el sitio web www.beimedplus.com

Está a punto de abandonar el sitio web www.beimedplus.com

Welcome to BeiMedPlus

Satellite Symposium: New avenues to improving outcomes for CLL patients

Therapeutic options for R/R B-cell malignancies

Therapeutic option for R/R FL

Therapeutic option for patients with R/R MZL

Therapeutic options for WM

Está a punto de abandonar el sitio web www.beimedplus.com

Está a punto de abandonar el sitio web www.beimedplus.com